← Leaderboards
Tamara Isakova
Northwestern University
$12,799,228
Attributed
$12,799,228
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,799,228 · 9
By mechanism
R01$5,333,737 · 2
TL1$3,241,926 · 1
P30$1,164,284 · 1
K23$844,594 · 1
U01$791,620 · 1
T32$642,557 · 1
Top collaborators
No co-investigators on record.
Most similar at Northwestern University
Same institution · by research overlap
- Chad A Mirkin$31,575,941
Others in their field
Top investigators on “Chronic Kidney Failure”
- John M Lachin · George Washington University$122,970,601
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$51,947,333
- Harold I Feldman · University Of Pennsylvania$48,933,882
- Jonathan Himmelfarb · Maine Medical Center$46,985,168
- Lisa P Jacobson · Johns Hopkins University$45,397,923
Research focus
Chronic Kidney FailureCardiovascular DiseasesDesignPathogenesisBiological MarkersMineralsMetabolismKidneyFutureCollaborationsNephrologyObservational StudyCessation Of LifeRisk FactorsIndexingSerumEnd Stage Renal FailureFundingResearch InfrastructureClinical TrialsComplicationInorganic PhosphateResearch PersonnelEvent
Grant awards (40)
NRSA Training Core$483,810
TL1 · FY2025 · DK · contact PI
Physical Activity/Physical Function and Longitudinal Changes in Cognitive Function in Adults with Chronic Kidney Disease.$39,221
TL1 · FY2025 · DK · contact PI
NRSA Training Core$722,691
TL1 · FY2024 · DK · contact PI
Mentored patient-oriented research of novel mechanisms for cardiovascular disease in patients with chronic kidney disease$114,404
K24 · FY2024 · HL · contact PI
NRSA Training Core$666,761
TL1 · FY2023 · DK · contact PI
Mentored patient-oriented research of novel mechanisms for cardiovascular disease in patients with chronic kidney disease$115,490
K24 · FY2023 · HL · contact PI
NRSA Training Core$661,698
TL1 · FY2022 · DK · contact PI
Clinical and Translational Core (Core C)$229,957
P30 · FY2022 · DK · contact PI
Mentored patient-oriented research of novel mechanisms for cardiovascular disease in patients with chronic kidney disease$116,349
K24 · FY2022 · HL · contact PI
NRSA Training Core$35,712
TL1 · FY2022 · DK · contact PI
NRSA Training Core$632,033
TL1 · FY2021 · DK · contact PI
Clinical and Translational Core (Core C)$232,159
P30 · FY2021 · DK · contact PI
Mentored patient-oriented research of novel mechanisms for cardiovascular disease in patients with chronic kidney disease$117,507
K24 · FY2021 · HL · contact PI
Novel Diagnostics and Therapeutic Targets for Calcification in CKD$437,861
R01 · FY2020 · DK · contact PI
Clinical and Translational Core (Core C)$234,056
P30 · FY2020 · DK · contact PI
NUKIDs: Scientist Training Program in Kidney Disease$210,104
T32 · FY2020 · DK · contact PI
Mentored patient-oriented research of novel mechanisms for cardiovascular disease in patients with chronic kidney disease$118,605
K24 · FY2020 · HL · contact PI
Novel Diagnostics and Therapeutic Targets for Calcification in CKD$437,861
R01 · FY2019 · DK · contact PI
Clinical and Translational Core (Core C)$234,056
P30 · FY2019 · DK · contact PI
NUKIDs: Scientist Training Program in Kidney Disease$216,236
T32 · FY2019 · DK · contact PI
Impact of phosphate and FGF23 reduction on intermediate end points in CKD$592,848
R01 · FY2018 · DK · contact PI
Novel Diagnostics and Therapeutic Targets for Calcification in CKD$407,470
R01 · FY2018 · DK · contact PI
Clinical and Translational Core (Core C)$234,056
P30 · FY2018 · DK · contact PI
NUKIDs: Scientist Training Program in Kidney Disease$216,217
T32 · FY2018 · DK · contact PI
Pilot Studies Targeting Mineral Metabolism in Chronic Kidney Disease$99,999
U01 · FY2018 · DK · contact PI
Impact of phosphate and FGF23 reduction on intermediate end points in CKD$589,062
R01 · FY2017 · DK · contact PI
Novel Diagnostics and Therapeutic Targets for Calcification in CKD$426,497
R01 · FY2017 · DK · contact PI
Pilot Studies Targeting Mineral Metabolism in Chronic Kidney Disease$347,781
U01 · FY2017 · DK · contact PI
Novel Diagnostics and Therapeutic Targets for Calcification in CKD$617,229
R01 · FY2016 · DK · contact PI
Impact of phosphate and FGF23 reduction on intermediate end points in CKD$591,523
R01 · FY2016 · DK · contact PI
Pilot Studies Targeting Mineral Metabolism in Chronic Kidney Disease$343,840
U01 · FY2016 · DK · contact PI
Impact of phosphate and FGF23 reduction on intermediate end points in CKD$595,878
R01 · FY2015 · DK · contact PI
FGF23 and mineral metabolism in Acute Kidney Injury$198,155
R21 · FY2015 · DK · contact PI
Impact of phosphate and FGF23 reduction on intermediate end points in CKD$637,508
R01 · FY2014 · DK · contact PI
Calcium Handling and Secondary Hyperparathyroidism in Chronic Kidney Disease$167,557
K23 · FY2014 · DK · contact PI
Calcium Handling and Secondary Hyperparathyroidism in Chronic Kidney Disease$156,904
K23 · FY2013 · DK · contact PI
Calcium Handling and Secondary Hyperparathyroidism in Chronic Kidney Disease$11,429
K23 · FY2013 · DK · contact PI
Calcium Handling and Secondary Hyperparathyroidism in Chronic Kidney Disease$169,082
K23 · FY2012 · DK · contact PI
Calcium Handling and Secondary Hyperparathyroidism in Chronic Kidney Disease$169,811
K23 · FY2011 · DK · contact PI
Calcium Handling and Secondary Hyperparathyroidism in Chronic Kidney Disease$169,811
K23 · FY2010 · DK · contact PI